Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Affordable and Safe Prescription Drug Importation Act
Client: HORIZON THERAPEUTICS USA, INC. (FKA HORIZON PHARMA USA, INC.) · Firm: HORIZON THERAPEUTICS USA, INC. (FKA HORIZON PHARMA USA, INC.)
HR 1628 "American Health Care Act of 2017," provisions pertaining to Subsection 2203(a)(4). HR 1245/S 469 "Affordable and Safe Prescription Drug Importation Act," all provisions. S 92 "Safe and Affordable Drugs from Canada Act of 2017," all provisions. Issues related to the implementation of PL 97-414 "Orphan Drug Act," all provisions. Issues related to the implementation of PL 111-148 "Patient Protection and Affordable Care Act," all provisions pertaining to the Center for Medicare and Medicaid Innovation (CMMI) and to Section 7102.
Affordable and Safe Prescription Drug Importation Act
Client: HORIZON THERAPEUTICS USA, INC. (FKA HORIZON PHARMA USA, INC.) · Firm: HORIZON THERAPEUTICS USA, INC. (FKA HORIZON PHARMA USA, INC.)
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
Issues related to the implementation of PL 111-148 "Patient Protection and Affordable Care Act," all provisions pertaining to the Center for Medicare and Medicaid Innovation (CMMI) and to Sections 7101 and 7102. Issues related to the implementation of PL 97-414 "Orphan Drug Act," all provisions. Issues pertaining to reauthorization of the Prescription Drug User Fee Act.
Issues relating to discussion draft of pending "Better Way for Tax Reform," all provisions pertaining to business tax reform. Issues relating to discussion draft of pending "Unified Framework for Fixing our Broken Tax Code," all provisions pertaining to business tax reform.
Source: Senate LDA
HR 1628 "American Health Care Act of 2017," provisions pertaining to Subsection 2203(a)(4). HR 1245/S 469 "Affordable and Safe Prescription Drug Importation Act," all provisions. S 92 "Safe and Affordable Drugs from Canada Act of 2017," all provisions. Issues related to the implementation of PL 97-414 "Orphan Drug Act," all provisions. Issues related to the implementation of PL 111-148 "Patient Protection and Affordable Care Act," all provisions pertaining to the Center for Medicare and Medicaid Innovation (CMMI) and to Section 7102. Issues pertaining to Reauthorization of the Prescription Drug User Fee Act.
American Health Care Act of 2017
Client: HORIZON THERAPEUTICS USA, INC. (FKA HORIZON PHARMA USA, INC.) · Firm: HORIZON THERAPEUTICS USA, INC. (FKA HORIZON PHARMA USA, INC.)
HR 1628 "American Health Care Act of 2017," provisions pertaining to Subsection 2203(a)(4). HR 1245/S 469 "Affordable and Safe Prescription Drug Importation Act," all provisions. S 92 "Safe and Affordable Drugs from Canada Act of 2017," all provisions. Issues related to the implementation of PL 97-414 "Orphan Drug Act," all provisions. Issues related to the implementation of PL 111-148 "Patient Protection and Affordable Care Act," all provisions pertaining to the Center for Medicare and Medicaid Innovation (CMMI) and to Section 7102. Issues pertaining to Reauthorization of the Prescription Drug User Fee Act.
American Health Care Act of 2017
Client: HORIZON THERAPEUTICS USA, INC. (FKA HORIZON PHARMA USA, INC.) · Firm: HORIZON THERAPEUTICS USA, INC. (FKA HORIZON PHARMA USA, INC.)
HR 1628 "American Health Care Act of 2017," provisions pertaining to Subsection 2203(a)(4). HR 1245/S 469 "Affordable and Safe Prescription Drug Importation Act," all provisions. S 92 "Safe and Affordable Drugs from Canada Act of 2017," all provisions. Issues related to the implementation of PL 97-414 "Orphan Drug Act," all provisions. Issues related to the implementation of PL 111-148 "Patient Protection and Affordable Care Act," all provisions pertaining to the Center for Medicare and Medicaid Innovation (CMMI) and to Section 7102.
Affordable and Safe Prescription Drug Importation Act
Client: HORIZON THERAPEUTICS USA, INC. (FKA HORIZON PHARMA USA, INC.) · Firm: HORIZON THERAPEUTICS USA, INC. (FKA HORIZON PHARMA USA, INC.)
HR 1628 "American Health Care Act of 2017," provisions pertaining to Subsection 2203(a)(4). HR 1245/S 469 "Affordable and Safe Prescription Drug Importation Act," all provisions. S 92 "Safe and Affordable Drugs from Canada Act of 2017," all provisions. Issues related to the implementation of PL 97-414 "Orphan Drug Act," all provisions. Issues related to the implementation of PL 111-148 "Patient Protection and Affordable Care Act," all provisions pertaining to the Center for Medicare and Medicaid Innovation (CMMI) and to Section 7102. Issues pertaining to Reauthorization of the Prescription Drug User Fee Act.
Affordable and Safe Prescription Drug Importation Act
Client: HORIZON THERAPEUTICS USA, INC. (FKA HORIZON PHARMA USA, INC.) · Firm: HORIZON THERAPEUTICS USA, INC. (FKA HORIZON PHARMA USA, INC.)
HR 1628 "American Health Care Act of 2017," provisions pertaining to Subsection 2203(a)(4). HR 1245/S 469 "Affordable and Safe Prescription Drug Importation Act," all provisions. S 92 "Safe and Affordable Drugs from Canada Act of 2017," all provisions. Issues related to the implementation of PL 97-414 "Orphan Drug Act," all provisions. Issues related to the implementation of PL 111-148 "Patient Protection and Affordable Care Act," all provisions pertaining to the Center for Medicare and Medicaid Innovation (CMMI) and to Section 7102.
Safe and Affordable Drugs from Canada Act of 2017
Client: HORIZON THERAPEUTICS USA, INC. (FKA HORIZON PHARMA USA, INC.) · Firm: HORIZON THERAPEUTICS USA, INC. (FKA HORIZON PHARMA USA, INC.)
HR 1628 "American Health Care Act of 2017," provisions pertaining to Subsection 2203(a)(4). HR 1245/S 469 "Affordable and Safe Prescription Drug Importation Act," all provisions. S 92 "Safe and Affordable Drugs from Canada Act of 2017," all provisions. Issues related to the implementation of PL 97-414 "Orphan Drug Act," all provisions. Issues related to the implementation of PL 111-148 "Patient Protection and Affordable Care Act," all provisions pertaining to the Center for Medicare and Medicaid Innovation (CMMI) and to Section 7102. Issues pertaining to Reauthorization of the Prescription Drug User Fee Act.
Safe and Affordable Drugs from Canada Act of 2017
Client: HORIZON THERAPEUTICS USA, INC. (FKA HORIZON PHARMA USA, INC.) · Firm: HORIZON THERAPEUTICS USA, INC. (FKA HORIZON PHARMA USA, INC.)
HR 1628 "American Health Care Act of 2017," provisions pertaining to Subsection 2203(a)(4). HR 1245/S 469 "Affordable and Safe Prescription Drug Importation Act," all provisions. S 92 "Safe and Affordable Drugs from Canada Act of 2017," all provisions. Issues related to the implementation of PL 97-414 "Orphan Drug Act," all provisions. Issues related to the implementation of PL 111-148 "Patient Protection and Affordable Care Act," all provisions pertaining to the Center for Medicare and Medicaid Innovation (CMMI) and to Section 7102.
Fostering Innovation Act of 2015
Client: HORIZON THERAPEUTICS USA, INC. (FKA HORIZON PHARMA USA, INC.) · Firm: HORIZON THERAPEUTICS USA, INC. (FKA HORIZON PHARMA USA, INC.)
HR 4139 "Fostering Innovation Act of 2015," all provisions.
To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models.
Client: HORIZON THERAPEUTICS USA, INC. (FKA HORIZON PHARMA USA, INC.) · Firm: HORIZON THERAPEUTICS USA, INC. (FKA HORIZON PHARMA USA, INC.)
Issues related to the implementation of PL 111-148 "Patient Protection and Affordable Care Act," all provisions pertaining to the Center for Medicare and Medicaid Innovation (CMMI). S 1878 "Advancing Hope Act of 2016," all provisions pertaining to extension of pediatric rare diseases priority review voucher program (PRV). HR 6 "21st Century Cures Act," all provisions relating to drug development and patient access. HR 5122 "To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models," all provisions.
To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models.
Client: HORIZON THERAPEUTICS USA, INC. (FKA HORIZON PHARMA USA, INC.) · Firm: HORIZON THERAPEUTICS USA, INC. (FKA HORIZON PHARMA USA, INC.)
Issues related to the implementation of PL 111-148 "Patient Protection and Affordable Care Act," all provisions pertaining to the Center for Medicare and Medicaid Innovation (CMMI). S 1878 "Advancing Hope Act of 2016," all provisions pertaining to extension of pediatric rare diseases priority review voucher program (PRV). HR 6 "21st Century Cures Act," all provisions relating to drug development and patient access. HR 5122 "To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models," all provisions.
21st Century Cures Act
Client: HORIZON THERAPEUTICS USA, INC. (FKA HORIZON PHARMA USA, INC.) · Firm: HORIZON THERAPEUTICS USA, INC. (FKA HORIZON PHARMA USA, INC.)
Issues related to the implementation of PL 111-148 "Patient Protection and Affordable Care Act," all provisions pertaining to the Center for Medicare and Medicaid Innovation (CMMI). S 1878 "Advancing Hope Act of 2016," all provisions pertaining to extension of pediatric rare diseases priority review voucher program (PRV). HR 6 "21st Century Cures Act," all provisions relating to drug development and patient access.
21st Century Cures Act
Client: HORIZON THERAPEUTICS USA, INC. (FKA HORIZON PHARMA USA, INC.) · Firm: HORIZON THERAPEUTICS USA, INC. (FKA HORIZON PHARMA USA, INC.)
Issues related to the implementation of PL 111-148 "Patient Protection and Affordable Care Act," all provisions pertaining to the Center for Medicare and Medicaid Innovation (CMMI). S 1878 "Advancing Hope Act of 2016," all provisions pertaining to extension of pediatric rare diseases priority review voucher program (PRV). HR 6 "21st Century Cures Act," all provisions relating to drug development and patient access. HR 5122 "To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models," all provisions.
21st Century Cures Act
Client: HORIZON THERAPEUTICS USA, INC. (FKA HORIZON PHARMA USA, INC.) · Firm: HORIZON THERAPEUTICS USA, INC. (FKA HORIZON PHARMA USA, INC.)
Issues related to the implementation of PL 111-148 "Patient Protection and Affordable Care Act," all provisions pertaining to the Center for Medicare and Medicaid Innovation (CMMI). S 1878 "Advancing Hope Act of 2016," all provisions pertaining to extension of pediatric rare diseases priority review voucher program (PRV). HR 6 "21st Century Cures Act," all provisions relating to drug development and patient access. HR 5122 "To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models," all provisions.
21st Century Cures Act
Client: HORIZON THERAPEUTICS USA, INC. (FKA HORIZON PHARMA USA, INC.) · Firm: HORIZON THERAPEUTICS USA, INC. (FKA HORIZON PHARMA USA, INC.)
Issues related to the implementation of PL 111-148 "Patient Protection and Affordable Care Act," all provisions pertaining to the Center for Medicare and Medicaid Innovation (CMMI). S 1878 "Advancing Hope Act of 2016," all provisions pertaining to extension of pediatric rare diseases priority review voucher program (PRV). HR 6 "21st Century Cures Act," all provisions relating to drug development and patient access.
Advancing Hope Act of 2016
Client: HORIZON THERAPEUTICS USA, INC. (FKA HORIZON PHARMA USA, INC.) · Firm: HORIZON THERAPEUTICS USA, INC. (FKA HORIZON PHARMA USA, INC.)
Issues related to the implementation of PL 111-148 "Patient Protection and Affordable Care Act," all provisions pertaining to the Center for Medicare and Medicaid Innovation (CMMI). S 1878 "Advancing Hope Act of 2016," all provisions pertaining to extension of pediatric rare diseases priority review voucher program (PRV). HR 6 "21st Century Cures Act," all provisions relating to drug development and patient access.
Advancing Hope Act of 2016
Client: HORIZON THERAPEUTICS USA, INC. (FKA HORIZON PHARMA USA, INC.) · Firm: HORIZON THERAPEUTICS USA, INC. (FKA HORIZON PHARMA USA, INC.)
Issues related to the implementation of PL 111-148 "Patient Protection and Affordable Care Act," all provisions pertaining to the Center for Medicare and Medicaid Innovation (CMMI). S 1878 "Advancing Hope Act of 2016," all provisions pertaining to extension of pediatric rare diseases priority review voucher program (PRV). HR 6 "21st Century Cures Act," all provisions relating to drug development and patient access. HR 5122 "To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models," all provisions.
Advancing Hope Act of 2016
Client: HORIZON THERAPEUTICS USA, INC. (FKA HORIZON PHARMA USA, INC.) · Firm: HORIZON THERAPEUTICS USA, INC. (FKA HORIZON PHARMA USA, INC.)
Issues related to the implementation of PL 111-148 "Patient Protection and Affordable Care Act," all provisions pertaining to the Center for Medicare and Medicaid Innovation (CMMI). S 1878 "Advancing Hope Act of 2016," all provisions pertaining to extension of pediatric rare diseases priority review voucher program (PRV). HR 6 "21st Century Cures Act," all provisions relating to drug development and patient access. HR 5122 "To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models," all provisions.
Advancing Hope Act of 2016
Client: HORIZON THERAPEUTICS USA, INC. (FKA HORIZON PHARMA USA, INC.) · Firm: HORIZON THERAPEUTICS USA, INC. (FKA HORIZON PHARMA USA, INC.)
Issues related to the implementation of PL 111-148 "Patient Protection and Affordable Care Act," all provisions pertaining to the Center for Medicare and Medicaid Innovation (CMMI). S 1878 "Advancing Hope Act of 2016," all provisions pertaining to extension of pediatric rare diseases priority review voucher program (PRV). HR 6 "21st Century Cures Act," all provisions relating to drug development and patient access.
Consolidated Appropriations Act, 2016
Client: HORIZON THERAPEUTICS USA, INC. (FKA HORIZON PHARMA USA, INC.) · Firm: HORIZON THERAPEUTICS USA, INC. (FKA HORIZON PHARMA USA, INC.)
HR 2029 "Consolidated Appropriations Act 2016," all provisions related to corporate tax.
21st Century Cures Act
Client: HORIZON THERAPEUTICS USA, INC. (FKA HORIZON PHARMA USA, INC.) · Firm: HORIZON THERAPEUTICS USA, INC. (FKA HORIZON PHARMA USA, INC.)
Issues pertaining to draft legislation called "Innovations for Healthier Americans," all provisions related to drug development & patient access. HR 6 "21st Century Cures Act," all provisions related to drug development & patient access.
Innovation Act
Client: HORIZON THERAPEUTICS USA, INC. (FKA HORIZON PHARMA USA, INC.) · Firm: HORIZON THERAPEUTICS USA, INC. (FKA HORIZON PHARMA USA, INC.)
HR 9 "Innovation Act," all provisions related to post-grant review reform. S 1137 "PATENT Act," all provisions related to post-grant review reform.
PATENT Act
Client: HORIZON THERAPEUTICS USA, INC. (FKA HORIZON PHARMA USA, INC.) · Firm: HORIZON THERAPEUTICS USA, INC. (FKA HORIZON PHARMA USA, INC.)
HR 9 "Innovation Act," all provisions related to post-grant review reform. S 1137 "PATENT Act," all provisions related to post-grant review reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HORIZON THERAPEUTICS USA, INC. (FKA HORIZON PHARMA USA, INC.) via HORIZON THERAPEUTICS USA, INC. (FKA HORIZON PHARMA USA, INC.)
2017 · second_quarter · Q2
Issues relating to discussion draft of pending "Better Way for Tax Reform," all provisions pertaining to business tax reform.
HR 1628 "American Health Care Act of 2017," provisions pertaining to Subsection 2203(a)(4). HR 1245/S 469 "Affordable and Safe Prescription Drug Importation Act," all provisions. S 92 "Safe and Affordable Drugs from Canada Act of 2017," all provisions. Issues related to the implementation of PL 97-414 "Orphan Drug Act," all provisions. Issues related to the implementation of PL 111-148 "Patient Protection and Affordable Care Act," all provisions pertaining to the Center for Medicare and Medicaid Innovation (CMMI) and to Section 7102. Issues pertaining to Reauthorization of the Prescription Drug User Fee Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HR 1628 "American Health Care Act of 2017," provisions pertaining to Subsection 2203(a)(4). HR 1245/S 469 "Affordable and Safe Prescription Drug Importation Act," all provisions. S 92 "Safe and Affordable Drugs from Canada Act of 2017," all provisions. Issues related to the implementation of PL 97-414 "Orphan Drug Act," all provisions. Issues related to the implementation of PL 111-148 "Patient Protection and Affordable Care Act," all provisions pertaining to the Center for Medicare and Medicaid Innovation (CMMI) and to Section 7102.
Issues relating to discussion draft of pending "Better Way for Tax Reform," all provisions.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HORIZON THERAPEUTICS USA, INC. (FKA HORIZON PHARMA USA, INC.) via HORIZON THERAPEUTICS USA, INC. (FKA HORIZON PHARMA USA, INC.)
2016 · fourth_quarter · Q4
Issues related to the implementation of PL 111-148 "Patient Protection and Affordable Care Act," all provisions pertaining to the Center for Medicare and Medicaid Innovation (CMMI). S 1878 "Advancing Hope Act of 2016," all provisions pertaining to extension of pediatric rare diseases priority review voucher program (PRV). HR 6 "21st Century Cures Act," all provisions relating to drug development and patient access. HR 5122 "To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models," all provisions.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to the implementation of PL 111-148 "Patient Protection and Affordable Care Act," all provisions pertaining to the Center for Medicare and Medicaid Innovation (CMMI). S 1878 "Advancing Hope Act of 2016," all provisions pertaining to extension of pediatric rare diseases priority review voucher program (PRV). HR 6 "21st Century Cures Act," all provisions relating to drug development and patient access. HR 5122 "To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models," all provisions.
Issues relating to Treasury and IRS proposed regulations under Section 385, all provisions.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HORIZON THERAPEUTICS USA, INC. (FKA HORIZON PHARMA USA, INC.) via HORIZON THERAPEUTICS USA, INC. (FKA HORIZON PHARMA USA, INC.)
2016 · second_quarter · Q2
Issues relating to Treasury and IRS proposed regulations under Section 385, all provisions.
Issues related to the implementation of PL 111-148 "Patient Protection and Affordable Care Act," all provisions pertaining to the Center for Medicare and Medicaid Innovation (CMMI). S 1878 "Advancing Hope Act of 2016," all provisions pertaining to extension of pediatric rare diseases priority review voucher program (PRV). HR 6 "21st Century Cures Act," all provisions relating to drug development and patient access.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HR 4139 "Fostering Innovation Act of 2015," all provisions.
Issues related to the implementation of PL 111-148 "Patient Protection and Affordable Care Act," all provisions pertaining to the Center for Medicare and Medicaid Innovation (CMMI). S 1878 "Advancing Hope Act of 2016," all provisions pertaining to extension of pediatric rare diseases priority review voucher program (PRV). HR 6 "21st Century Cures Act," all provisions relating to drug development and patient access.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HORIZON THERAPEUTICS USA, INC. (FKA HORIZON PHARMA USA, INC.) via HORIZON THERAPEUTICS USA, INC. (FKA HORIZON PHARMA USA, INC.)
2015 · fourth_quarter · Q4
HR 2029 "Consolidated Appropriations Act 2016," all provisions related to corporate tax.
Issues pertaining to draft legislation called "Innovations for Healthier Americans," all provisions related to drug development & patient access. HR 6 "21st Century Cures Act," all provisions related to drug development & patient access.
HR 9 "Innovation Act," all provisions related to post-grant review reform. S 1137 "PATENT Act," all provisions related to post-grant review reform.
HORIZON THERAPEUTICS USA, INC. (FKA HORIZON PHARMA USA, INC.) via HORIZON THERAPEUTICS USA, INC. (FKA HORIZON PHARMA USA, INC.)
2015 · fourth_quarter · RR
Legislative and regulatory issues related to biotechnology pharmaceuticals.
Legislative and regulatory issues related to biotechnology pharmaceuticals.
Legislative and regulatory issues related to biotechnology pharmaceuticals.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Legislative and regulatory issues related to biotechnology pharmaceuticals.
Legislative and regulatory issues related to biotechnology pharmaceuticals.
Legislative and regulatory issues related to biotechnology pharmaceuticals.